During the past decade, Dawes Fretzin Clinical Research Group, LLC conducted 87 clinical trials. In the 10-year time frame, 87 clinical trials started and 47 clinical trials were completed, i.e. on average, 54% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 30 clinical trials were completed. i.e. 88.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dawes Fretzin Clinical Research Group, LLC" #1 sponsor was "Pfizer" with 18 trials, followed by "Eli Lilly and Company" with 14 trials sponsored, "Janssen Research & Development, LLC" with 11 trials sponsored, "Amgen" with 7 trials sponsored and "LEO Pharma" with 7 trials sponsored. Other sponsors include 60 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dawes Fretzin Clinical Research Group, LLC" #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator, "Incyte Corporation" with 3 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator, "Nektar Therapeutics" with 2 trials as a collaborator and "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Dawes Fretzin Clinical Research Group, LLC" are "Psoriasis" (24 trials), "Atopic Dermatitis" (23 trials), "Plaque Psoriasis" (13 trials), "Alopecia Areata" (8 trials) and "Dermatitis, Atopic" (7 trials). Many other conditions were trialed in "Dawes Fretzin Clinical Research Group, LLC" in a lesser frequency.

Most popular intervention types in "Dawes Fretzin Clinical Research Group, LLC" are "Drug" (110 trials), "Other" (11 trials), "Biological" (10 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (51 trials), "Guselkumab" (5 trials), "ASN002" (3 trials), "Apremilast" (3 trials) and "Baricitinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Dawes Fretzin Clinical Research Group, LLC" are 118 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Dawes Fretzin Clinical Research Group, LLC". undefined are not yet recruiting, 12 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 80 completed trials in Dawes Fretzin Clinical Research Group, LLC, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Dawes Fretzin Clinical Research Group, LLC, 6 "Phase 1" clinical trials were conducted, 51 "Phase 2" clinical trials and 53 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 1 trials that are defined as “Not Applicable".